Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome
- PMID: 26410745
- DOI: 10.1007/s00415-015-7897-y
Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome
Abstract
The objective of this study is to describe a case of severe and treatment-resistant neurological Behçet's syndrome responsive to a novel therapy. This case report describes the patient who failed to respond to conventional therapy but the brain stem lesion resolved with the anti-CD20 biological agent rituximab. Neurological complications are uncommon in Behçet's syndrome; 80% involve a meningoencephalitis which can be severe and relapsing. This is the first report of effectiveness of rituximab in this uncommon disease.
Keywords: Behçet’s syndrome; Neurological; Rituximab; Treatment.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical